Related Experiment Video
Updated: May 3, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Loss of duplexmiR-223 (5p and 3p) aggravates myocardial depression and mortality in polymicrobial sepsis
Xiaohong Wang1, Wei Huang2, Yang Yang1
1Department of Pharmacology and Cell Biophysics.
Abstract:
Sepsis is the leading cause of death in critically ill patients. While myocardial dysfunction has been recognized as a major manifestation in severe sepsis, the underlying molecular mechanisms associated with septic cardiomyopathy remain unclear. In this study, we performed a miRNA array analysis in hearts collected from a severe septic mouse model induced by cecal ligation and puncture (CLP). Among the 19 miRNAs that were dys-regulated in CLP-mouse hearts, miR-223(3p) and miR-223*(5p) were most significantly downregulated, compared with sham-operated mouse hearts. To test whether a drop of miR-223 duplex plays any roles in sepsis-induced cardiac dysfunction and inflammation, a knockout (KO) mouse model with a deletion of the miR-223 gene locus and wild-type (WT) mice were subjected to CLP or sham surgery. We observed that sepsis-induced cardiac dysfunction, inflammatory response and mortality were remarkably aggravated in CLP-treated KO mice, compared with control WTs. Using Western-blotting and luciferase reporter assays, we identified Sema3A, an activator of cytokine storm and a neural chemorepellent for sympathetic axons, as an authentic target of miR-223* in the myocardium. In addition, we validated that miR-223 negatively regulated the expression of STAT-3 and IL-6 in mouse hearts. Furthermore, injection of Sema3A protein into WT mice revealed an exacerbation of sepsis-triggered inflammatory response and myocardial depression, compared with control IgG1 protein-treated WT mice following CLP surgery. Taken together, these data indicate that loss of miR-223/-223* causes an aggravation of sepsis-induced inflammation, myocardial dysfunction and mortality. Our study uncovers a previously unrecognized mechanism underlying septic cardiomyopathy and thereby, may provide a new strategy to treat sepsis.
Insights
Loss of miR-223 duplex worsens sepsis-induced heart dysfunction and inflammation. This study identifies miR-223 as a key regulator in septic cardiomyopathy, offering potential new therapeutic targets.
Area of Science:
- Cardiology
- Molecular Biology
- Immunology
Background:
- Sepsis is a leading cause of death, with septic cardiomyopathy a significant complication.
- Molecular mechanisms of septic cardiomyopathy are not fully understood.
Purpose of the Study:
- Investigate the role of miR-223 in sepsis-induced cardiac dysfunction.
- Identify molecular targets of miR-223 in the heart during sepsis.
Main Methods:
- MicroRNA array analysis in a mouse model of sepsis (cecal ligation and puncture).
- Comparison of wild-type and miR-223 knockout mice subjected to sepsis.
- Western blotting and luciferase reporter assays to identify miR-223 targets.
- In vivo validation of target protein effects.
Main Results:
- miR-223 was significantly downregulated in septic mouse hearts.
- miR-223 knockout mice showed exacerbated cardiac dysfunction, inflammation, and mortality during sepsis.
- Sema3A was identified as a direct target of miR-223* in the myocardium.
- miR-223 negatively regulated STAT-3 and IL-6 expression.
Conclusions:
- Loss of miR-223 exacerbates sepsis-induced inflammation, myocardial dysfunction, and mortality.
- miR-223 plays a protective role against septic cardiomyopathy.
- This study reveals a novel mechanism in septic cardiomyopathy and suggests miR-223 as a therapeutic target.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Endocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests

